RA
TCRT icon

Royce & Associates’s Alaunos Therapeutics TCRT Stock Holding History

Royce & Associates’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,787
Closed -$708K – 1379
2014
Q3 		$708K Hold
1,787
– – ﹤0.01% 1173
2014
Q2 		$1.08M Sell
1,787
-420
-19% -$234K ﹤0.01% 1136
2014
Q1 		$1.52M Sell
2,207
-233
-10% -$156K ﹤0.01% 1096
2013
Q4 		$1.59M Sell
2,440
-1,400
-36% -$834K ﹤0.01% 1107
2013
Q3 		$2.27M Sell
3,840
-560
-13% -$252K 0.01% 1042
2013
Q2 		$1.39M Buy
+4,400
New +$1.22M ﹤0.01% 1110

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $56.7M AUM 2.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return